ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab granted Priority Review in the US as 1st-line treatment for patients with HER2-positive metastatic breast cancer

businesswire

ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab granted Priority Review in the US as 1st-line treatment for patients with HER2-positive metastatic breast cancer – NEWSnet – News… as it used to be

More Press Releases

June 18, 2026

Two Florida Family Law Firms Named Among the State’s Best Divorce Practices for 2026

June 18, 2026

/C O R R E C T I O N — MTS Logistics/

June 18, 2026

Dynamic SEO Rebrands as Fire Fuel SEO, the Best Tucson SEO Agency Built for Home Service & Construction Businesses

June 18, 2026

ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab granted Priority Review in the US as 1st-line treatment for patients with HER2-positive metastatic breast cancer

Two Florida Family Law Firms Named Among the State’s Best Divorce Practices for 2026

/C O R R E C T I O N — MTS Logistics/

Dynamic SEO Rebrands as Fire Fuel SEO, the Best Tucson SEO Agency Built for Home Service & Construction Businesses

SCIENTIFIC GLOBAL NAMED TO MM+M AGENCY 100 2026